Author Bio
Taylor Carmichael is a former attorney and filmmaker. He's the author of a line of murder mysteries, including Whodidit in the Supreme Court? and Whodidit With a Senator? The majority of what he knows about stocks he learned right here at the Motley Fool.
In December, the Food and Drug Administration (FDA) gave emergency use authorizations (EUA) to the mRNA vaccines from
Pfizer (NYSE:PFE). Since then, the two companies have seized the lion share of the vaccine market in the U.S.
Meanwhile, the
Novavax (NASDAQ:NVAX) vaccine has been delayed, and the company now hopes that it will receive an EUA in July. Will there be any vaccine market left for the biotech upstart? In this clip from